Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 100 citing articles:

Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
Norberto Perico, Monica Cortinovis, Fredy Suter, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e22-e33
Open Access | Times Cited: 66
NSAIDs and COVID-19: A Systematic Review and Meta-analysis
Nicholas Moore, Pauline Bosco‐Lévy, Nicolas H. Thurin, et al.
Drug Safety (2021) Vol. 44, Iss. 9, pp. 929-938
Open Access | Times Cited: 79
Unboxing the molecular modalities of mutagens in cancer
Smita Kumari, Sudhanshu Sharma, Dia Advani, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 41, pp. 62111-62159
Open Access | Times Cited: 72
SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression
Swati Goel, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 65
A review of the toxicology presence and removal of ketoprofen through adsorption technology
Jordana Georgin, Dison S.P. Franco, Kátia da Boit Martinello, et al.
Journal of environmental chemical engineering (2022) Vol. 10, Iss. 3, pp. 107798-107798
Closed Access | Times Cited: 55
Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup
Huikang Xu, Shiying Sheng, Weiwei Luo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Rational design of ionic covalent organic frameworks for PPCPs elimination: Insights into ibuprofen adsorption performance and mechanism
Yu‐Lin Li, Yuhan Jin, Minghao Liu, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 685, pp. 133309-133309
Closed Access | Times Cited: 11
Ferromanganese oxide-functionalized TiO2 for rapid catalytic ozonation of PPCPs through a coordinated oxidation process with adjusted composition and strengthened generation of reactive oxygen species
Na You, Shihai Deng, Haiyang He, et al.
Water Research (2024) Vol. 258, pp. 121813-121813
Closed Access | Times Cited: 10
Single and binary adsorption of paracetamol and diclofenac onto biochar produced from pepper stem: Which adsorption properties change in the binary system?
Naima Azri, Rachid Chebbi, Abdelkader Ouakouak, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 694, pp. 134136-134136
Closed Access | Times Cited: 7
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
Е. Л. Насонов, А. М. Лила, Mazurov Vi, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 3, pp. 239-254
Open Access | Times Cited: 49
Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
Mina Kelleni
SN Comprehensive Clinical Medicine (2021) Vol. 3, Iss. 4, pp. 919-923
Open Access | Times Cited: 48
Evolution of SARS CoV-2 Omicron subvariants BF.7 and XBB.1.5: Time to follow Africa and abort all COVID restrictions
Mina Kelleni
Journal of Infection (2023) Vol. 86, Iss. 4, pp. 405-405
Open Access | Times Cited: 20
Copper(II) complexes with non-steroidal anti-inflammatory drugs and neocuproine: Structure and biological evaluation
Georgios Malis, Anastasia S. Bakali, Antonios G. Hatzidimitriou, et al.
Journal of Molecular Structure (2024) Vol. 1303, pp. 137590-137590
Closed Access | Times Cited: 5
New formulation of ibuprofen-arginate reduces oxidative stress and prevents macrophage polarization toward M1 phenotype
María Soledad Álvarez, Luciana Mazzei, María Belén Hapon, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117819-117819
Open Access
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects
Mina Kelleni
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 1, pp. 17-21
Open Access | Times Cited: 35
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
Donovan McGrowder, Fabian Miller, Melisa Anderson Cross, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 50-50
Open Access | Times Cited: 32
Enhancing catalytic ozonation activity of MCM-41 via one-step incorporating fluorine and iron: The interfacial reaction induced by hydrophobic sites and Lewis acid sites
Dongpo Liu, Muxin Lin, Weirui Chen, et al.
Chemosphere (2022) Vol. 292, pp. 133544-133544
Closed Access | Times Cited: 23
Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants
Kyonghwan Choe, Hyun‐Young Park, Muhammad Ikram, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1298-1298
Open Access | Times Cited: 22
In Vitro Antiviral and Anti-Inflammatory Activities of N-Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory Infections
М. Marchetti, Barbara De Berardis, Irene Bigioni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5129-5129
Open Access | Times Cited: 12
Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations
Neha Dabholkar, Srividya Gorantla, Sunil Kumar Dubey, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112023-112023
Open Access | Times Cited: 31
Targeting cyclooxygenase enzyme for the adjuvant COVID‐19 therapy
Parteek Prasher, Mousmee Sharma, Ravi Gunupuru
Drug Development Research (2021) Vol. 82, Iss. 4, pp. 469-473
Open Access | Times Cited: 27
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
Pawan Kumar Raghav, Zoya Mann, Simran Kaur Ahluwalia, et al.
Journal of Pharmacological Sciences (2023) Vol. 152, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
Application of Lipase B from Candida antarctica in the Pharmaceutical Industry
Honghai Wang, Qiang Zhang, Yu Xiong, et al.
Industrial & Engineering Chemistry Research (2023) Vol. 62, Iss. 39, pp. 15733-15751
Closed Access | Times Cited: 11
Ketoprofen as an emerging contaminant: occurrence, ecotoxicity and (bio)removal
Elena A. Tyumina, Maria Subbotina, Maxim Polygalov, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
Using informative features in machine learning based method for COVID-19 drug repurposing
Rosa Aghdam, Mahnaz Habibi, Golnaz Taheri
Journal of Cheminformatics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top